Clinical Trial Update: A Study Evaluating The Safety, Tolerability, Pharmacokinetics, And Efficacy Of Venetoclax In Combination With Atezolizumab, Carboplatin, And Etoposide In Participants With Untreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC). [Phase 1]

View source ↗

Summary

Phase 1 study evaluating venetoclax with atezolizumab, carboplatin, and etoposide in untreated extensive-stage small cell lung cancer was terminated; results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)
• Venetoclax (venetoclax)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Small Cell Lung Cancer | Phase 1 | Status: TERMINATED | Results posted: 2021-11-08